Moreover, inhibition of GSDMD with DSF attenuates the bacterial infection-associated PD behavioral phenotype and dopaminergic neuron loss.459 These results suggest that GSDMD represents a promising new therapeutic target for PD, but further studies are needed to confirm its therapeutic potential and to elucidate the precise mechanisms underlying its action. Here, GSDMD is linked to bacterial infectious disease.